https://www.selleckchem.com/products/unc0642.html
Future studies are required to relate the complex mechanisms underlying chronic inflammation in CRS to dysfunction of the olfactory system. Subcutaneous venom immunotherapy (VIT) represents an effective treatment against bee venom allergy. However, it involves long treatment times, high costs, and the risk of adverse events (AEs). Shorter, safer, and cheaper treatment options are therefore pursued. To determine the safety, immunogenicity, and efficacy of bee venom intralymphatic immunotherapy (ILIT). In an open pilot study, 12 patients
Like
Comment
Share
